Market studies suggest that the global digital health market (DHM) will grow on average at double-digit rates over the next five years.
Recent Cullen International global research shows that most of the ten researched jurisdictions have national digital health strategies. Five of these jurisdictions have comprehensive national digital health strategies in place. In three others, digital health is one part of a wider health sector strategy or national digital transformation strategy.
All the researched jurisdictions have extended the scope of medical devices, so that software is considered a medical device under certain uses. Moreover, most have laws, regulations or guidelines on telehealth or telemedicine.
This Global Trends report covers Australia, Brazil, China, the EU, India, Japan, Korea, Singapore, South Africa and the US. It analyses:
- the size of the national DHMs;
- the national policies on digital health; and
- regulations on software as a medical device (SaMD) and telehealth or telemedicine services.
For more information and to access the full report, please click on “Access the full content” - or on “Request Access”, in case you are not subscribed to the Global Trends service.
more news
03 April 26
Spectrum policy and new consumer protection rules in the LATAM telecoms market
Cullen International’s latest LATAM Telecoms Update highlights policy developments over the past three months affecting the regulation of radio spectrum, wholesale networks and consumer protection in six markets in the region: Argentina, Brazil, Chile, Colombia, Mexico and Peru.
30 March 26
Transposition status of key EU environmental directives
Our latest benchmark contains summary information on the transposition status of six key EU environmental directives.
26 March 26
What are New Competition Tools and who wields them?
Our new benchmark surveys which European countries have introduced so-called new competition tools (NCTs), also known as market investigation powers. NCTs enable competition authorities to intervene in markets without establishing an infringement of antitrust rules.